SCHEMBL179537

SCHEMBL179537

CC(C)(C)C(=O)NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11239351 0.97
SCHEMBL18275057 0.97
SCHEMBL18275048 0.97
Acetic Acid SCHEMBL11487838 0.91 HDAC6 (0.43)
Trifluoromethanesulfonic Acid SCHEMBL17786794 0.80 CA2 (0.44)
SCHEMBL20970392 0.76 CYP1A2 (0.40)
SCHEMBL5690876 0.74 CYP1A2 (0.48)
SCHEMBL6635776 0.74 L3MBTL1 (0.46)
SCHEMBL24465094 0.73 CA2 (0.43)
SCHEMBL13816830 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119176819-B Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase 山东第二医科大学 2025-02-14 CN claimed
CN-119176819-A Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase 山东第二医科大学 2024-12-24 CN claimed
US-4207091-A HYDROZAMIC ACID DERIVATIVES CIBA-GEIGY CORPORATION (US) 1980-06-10 US claimed
CN-119176819-B Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase 山东第二医科大学 2025-02-14 CN disclosed
CN-119176819-A Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase 山东第二医科大学 2024-12-24 CN disclosed
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 CN disclosed
US-20240209000-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE LLC 2024-06-27 US disclosed
US-20240209000-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE LLC 2024-06-27 US disclosed
US-11840521-B2 Modulators of Mas-related G-protein receptor X4 and related products and methods ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-12 US disclosed
US-20230364097-A1 TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS INFINITY PHARMACEUTICALS, INC. (US) 2023-11-16 US disclosed
US-20230277570-A1 ENPP1 Inhibitors and Their Use for the Treatment of Cancer THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2023-09-07 US disclosed
US-4935494-A C-terminal peptide and protein sequencing CITY OF HOPE (US) 1990-06-19 US disclosed
WO-1990005739-A1 CARBOXYL TERMINAL PEPTIDE AND PROTEIN SEQUENCING MILLER CHAD G (US) 1990-05-31 WO disclosed
US-4742176-A Process for 2-[(2-chlorophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone FMC CORPORATION (US) 1988-05-03 US disclosed
US-4686302-A Simultaneous preparation of nitriles and acrylamide or methacrylamide BASF AKTIENGESELLSCHAFT (DE) 1987-08-11 US disclosed
EP-0086492-B1 N-((ALKYLAMINO)CARBONYL)-N-(((ALKYLAMINO)-CARBONYL)OXY)ACYLAMIDES WITH ANTINEOPLASTIC ACTIVITY THE DOW CHEMICAL COMPANY (US) 1986-09-10 EP disclosed
US-4413009-A N-((Alkylamino)carbonyl)-N-(((alkylamino)carbonyl)oxy)acylamides with antineoplastic activity THE DOW CHEMICAL COMPANY (US) 1983-11-01 US disclosed
EP-0086492-A2 N-((alkylamino)carbonyl)-N-(((alkylamino)-carbonyl)oxy)acylamides with antineoplastic activity THE DOW CHEMICAL COMPANY (US) 1983-08-24 EP disclosed
US-4059699-A O,O-diethyl-O-carboxamidophosphate esters and use to combat insects and mites GULF OIL CORPORATION (US) 1977-11-22 US disclosed
US-3994997-A MITICIDES, INSECTICIDES GULF OIL CORPORATION (US) 1976-11-30 US disclosed